https://www.selleckchem.com/products/sq22536.html
Manifest CAN were more frequently presented in patients with schizophrenia (39% vs. 6% for controls, .0001). Sensitivity analysis of 41 subjects with schizophrenia without diabetes matched to 41 psychiatric healthy controls, showed similar results (37% vs. 5% for controls, .0001). CAN is highly prevalent in patients with schizophrenia. Testing for CAN is feasible and might be a new clinically tool for detecting early stages of CVD in patients with schizophrenia. CAN is highly prevalent in patients with schizophrenia. Testing for
Like
Comment
Share
